Amiglyde-V Intrauterine Solution, 250mg/mL

Supplied By: Zoetis (10004013)


SKU
004110


Unit of
Measure
48mL


Pack
Type
Vial


Case
Qty
24

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023
{{purchaseHistoryItem}}


SKU
004110


Size
48mL

Case
Qty
24

Purchase History

May- 2024 {{productPurchaseHistory['004110'][0]}} Oct- 2023 {{productPurchaseHistory['004110'][0+7]}}
Apr- 2024 {{productPurchaseHistory['004110'][1]}} Sep- 2023 {{productPurchaseHistory['004110'][1+7]}}
Mar- 2024 {{productPurchaseHistory['004110'][2]}} Aug- 2023 {{productPurchaseHistory['004110'][2+7]}}
Feb- 2024 {{productPurchaseHistory['004110'][3]}} Jul- 2023 {{productPurchaseHistory['004110'][3+7]}}
Jan- 2024 {{productPurchaseHistory['004110'][4]}} Jun- 2023 {{productPurchaseHistory['004110'][4+7]}}
Dec- 2023 {{productPurchaseHistory['004110'][5]}} May- 2023 {{productPurchaseHistory['004110'][5+7]}}
Nov- 2023 {{productPurchaseHistory['004110'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Amiglyde-V® is indicated for the treatment of uterine infections (endometritis, metritis and pyometra) in mares, when caused by susceptible organisms including Escherichia coli, Pseudomonas sp and Klebsiella sp. The use of Amiglyde-V in eliminating infections caused by the above organisms has been shown clinically to improve fertility in infected mares.

Features & Benefits

  • Plasma protein binding of sulfadimethoxine is high, creating a drug reservoir in the blood that maintains higher blood levels than most other long-acting sulfonamides
  • A single, daily dose gives rapid and sustained therapeutic blood levels for 24 hours
  • Daily dosing increases likelihood of compliance, potentially improving outcomes
  • Available as a tablet and a palatable custard-flavored suspension that eases administration